The Chemours Company, a global chemistry firm, reported its first-quarter 2026 results on Thursday, showing stable revenue growth but wider net losses amid higher costs and financing charges.

 

The company posted Net Sales of $1.4 billion, up slightly from the prior-year quarter, supported by stronger pricing and currency gains. Growth in Thermal & Specialized Solutions—driven by continued adoption of Opteon refrigerants—helped offset weaker volumes in other segments.

 

Chemours reported a Net Loss attributable to the company of $29 million, or $0.19 per diluted share, compared with a loss of $5 million, or $0.03 per diluted share, a year earlier. The widening loss was attributed to higher financing costs linked to recent debt issuance and increased selling, general and administrative expenses.

 

Adjusted Net Income came in at $8 million, or $0.05 per diluted share, down from $19 million, or $0.13 per diluted share, in the prior-year period. Meanwhile, Adjusted EBITDA edged up to $169 million from $166 million, as pricing and currency benefits helped offset rising costs and weaker volumes in parts of the business.

 

A key highlight was the performance of the TSS segment, where demand for next-generation refrigerants continued to accelerate. The segment posted record first-quarter Net Sales of $568 million, up 22% year-over-year, driven by double-digit growth in Opteon refrigerants and stronger automotive Freon pricing in North America.

 

Adjusted EBITDA for TSS surged 35% to $190 million, with margins expanding to 33%, reflecting improved product mix and pricing strength.

 

However, the company also faced headwinds. Lower volumes in Titanium Technologies and Advanced Performance Materials were driven by weaker cyclical demand and an operational outage in APM.

 

Chemours also announced a global TiO2 price increase effective April 1, 2026, extending earlier pricing actions. Sequential TiO2 pricing rose 3% in the quarter.

 

On the balance sheet, the company strengthened its financial position by securing approximately $287 million in net proceeds from the sale of its Kuan Yin site, which will be used in part to repay €140 million of outstanding debt.

 

“Chemours exceeded overall expectations in the first quarter, achieving strong outcomes from both our TSS and TT businesses, paired with the more recent receipt of cash through the completion of a substantial portion of our Kuan Yin property sales enabling us to reduce our debt,” stated Denise Dignam, Chemours President and CEO. 

 

“These achievements demonstrate our dedication to our Pathway to Thrive strategy and highlight the importance we place on effective execution. While the wider economic landscape remains uncertain, Chemours continues to drive full-year growth while remaining steadfast in prioritizing flexible commercial and operational strategies to ensure Chemours is able to capitalize on opportunities in our key markets.”

 

Looking ahead, Chemours said it remains focused on balancing cost pressures, debt reduction, and continued expansion in high-growth refrigerant markets, even as broader industrial demand remains uneven.